rs1511024
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000134.4(FABP2):c.*15G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0337 in 1,585,764 control chromosomes in the GnomAD database, including 1,113 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.041 ( 193 hom., cov: 32)
Exomes 𝑓: 0.033 ( 920 hom. )
Consequence
FABP2
NM_000134.4 3_prime_UTR
NM_000134.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.286
Publications
9 publications found
Genes affected
FABP2 (HGNC:3556): (fatty acid binding protein 2) The protein encoded by this gene is an intracellular fatty acid-binding protein that participates in the uptake, intracellular metabolism, and transport of long-chain fatty acids. The encoded protein is also involved in the modulation of cell growth and proliferation. This protein binds saturated long-chain fatty acids with high affinity, and may act as a lipid sensor to maintain energy homeostasis. [provided by RefSeq, Aug 2017]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 4-119319026-C-T is Benign according to our data. Variant chr4-119319026-C-T is described in ClinVar as Benign. ClinVar VariationId is 1226479.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0621 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0414 AC: 6292AN: 151858Hom.: 191 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
6292
AN:
151858
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0325 AC: 7602AN: 234116 AF XY: 0.0330 show subpopulations
GnomAD2 exomes
AF:
AC:
7602
AN:
234116
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0329 AC: 47174AN: 1433788Hom.: 920 Cov.: 28 AF XY: 0.0330 AC XY: 23580AN XY: 714010 show subpopulations
GnomAD4 exome
AF:
AC:
47174
AN:
1433788
Hom.:
Cov.:
28
AF XY:
AC XY:
23580
AN XY:
714010
show subpopulations
African (AFR)
AF:
AC:
1849
AN:
31654
American (AMR)
AF:
AC:
864
AN:
40736
Ashkenazi Jewish (ASJ)
AF:
AC:
432
AN:
25770
East Asian (EAS)
AF:
AC:
557
AN:
37788
South Asian (SAS)
AF:
AC:
3099
AN:
83324
European-Finnish (FIN)
AF:
AC:
2062
AN:
53128
Middle Eastern (MID)
AF:
AC:
587
AN:
5658
European-Non Finnish (NFE)
AF:
AC:
35659
AN:
1096554
Other (OTH)
AF:
AC:
2065
AN:
59176
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.419
Heterozygous variant carriers
0
1875
3750
5626
7501
9376
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
1296
2592
3888
5184
6480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0415 AC: 6301AN: 151976Hom.: 193 Cov.: 32 AF XY: 0.0418 AC XY: 3106AN XY: 74292 show subpopulations
GnomAD4 genome
AF:
AC:
6301
AN:
151976
Hom.:
Cov.:
32
AF XY:
AC XY:
3106
AN XY:
74292
show subpopulations
African (AFR)
AF:
AC:
2662
AN:
41498
American (AMR)
AF:
AC:
517
AN:
15246
Ashkenazi Jewish (ASJ)
AF:
AC:
55
AN:
3462
East Asian (EAS)
AF:
AC:
30
AN:
5176
South Asian (SAS)
AF:
AC:
155
AN:
4818
European-Finnish (FIN)
AF:
AC:
393
AN:
10548
Middle Eastern (MID)
AF:
AC:
27
AN:
294
European-Non Finnish (NFE)
AF:
AC:
2309
AN:
67918
Other (OTH)
AF:
AC:
94
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
317
635
952
1270
1587
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
78
156
234
312
390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
124
AN:
3458
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 20, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.